Molecular determinants of human dipeptidyl peptidase III sensitivity to thiol modifying reagents by Karačić, Zrinka et al.
 DOI 10.1515/hsz-2012-0181   Biol. Chem., 2012; 393(12): 1523–1532
 Zrinka  Kara č i ć a ,  Jasminka  Š poljari ć a ,  Marko  Ro ž man and  Marija  Abrami ć * 
 Molecular determinants of human dipeptidyl 
peptidase III sensitivity to thiol modifying 
reagents 
 Abstract :  Human dipeptidyl peptidase III (DPP III) is a 
member of the metallopeptidase family M49, involved in 
protein metabolism and oxidative stress response. DPP 
III crystal structure shows the two lobe-like domains 
separated by a wide cleft. The human enzyme has a 
total of six cysteines, three in the lower (Cys19, Cys147, 
and Cys176) and three in the upper (Cys509, Cys519, 
and Cys654), catalytic, domain containing the active-
site zinc ion. To elucidate the molecular basis of this 
enzyme ’ s susceptibility to sulfhydryl reagents, bio-
chemical analysis of a set of Cys to Ala mutants was 
used, supported by mass spectrometry. Cys176, a residue 
44  Å apart from the catalytic center of the ligand-free 
enzyme, was found responsible for the inactivation with 
the submicromolar concentration of an organomercu-
rial compound, and three additional cysteines contri-
buted to sensitivity to aromatic disulfides. Upon treat-
ment with oxidized glutathione [glutathione disulfide 
(GSSG)], cysteine residues at positions 147, 176, and 654 
were found glutathionylated. The mutational analy-
sis confirmed the involvement of Cys176 and Cys654 in 
human DPP III inactivation by GSSG. Observation that 
Cys176, a residue quite distant from the active center, 
contributes to enzyme inactivation, indicates that the 
substrate-binding site of human DPP III comprises both 
lower and upper protein domain. 
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 Introduction 
 Dipeptidyl peptidase III (DPP III, EC 3.4.14.4) is a mono-
zinc metalloexopeptidase, which  in vitro hydrolyzes a 
number of biologically active peptides by cleaving dipep-
tides from their N-termini (Abrami ć et al., 1988 ; Chen and 
Barrett , 2004 ). This type of enzyme is broadly distributed 
in mammalian tissues and biochemically characterized 
from several eukaryotic sources (Fukasawa et al. , 1998 ; 
Chen and Barrett , 2004 ; Jaj č anin-Jozi ć et al., 2010 ). Based 
on the large proteomics datasets measured from seven 
human cell lines, DPP III is identified as a member of 
the human central proteome (Burkard et al. , 2011 ). It is 
thought that this peptidase participates in normal intra-
cellular protein catabolism, in the pain modulation, and 
in endogenous defense against oxidative stress (Chiba 
et al. , 2003 ; Bar š un et al., 2007 ; Liu et al. , 2007 ). A path-
ological role is indicated for DPP III in cataractogenesis 
and in malignant growth (Zhang et al. , 2001 ;  Š imaga 
et al., 2003 ). Most recent clinical cancer research revealed 
the diagnostic and prognostic value of human DPP III as a 
constituent of the six-gene model (He et al. , 2010 ). 
 Human DPP III belongs to the M49 family of metal-
lopeptidases (DPP III family) (MEROPS database: http://
merops.sanger.ac.uk/) with five evolutionary conserved 
amino acid sequence regions (Abrami ć et al., 2004a ). 
Crystal structures of two members of this family have been 
solved, yeast and human ortholog, both ligand-free (PDB: 
3csk and 3fvy, respectively). These structures reveal that 
DPP III is a two-domain protein: upper domain (C-termi-
nal) with the catalytic zinc ion bound, is mostly helical, 
separated by a wide cleft from the lower domain (N-ter-
minal), comprising mixed  α - and  β -secondary structures 
(Baral et al. , 2008 ). The zinc-binding site of the human 
DPP III is built up by His450, His455, and Glu508. The two 
histidine ligands belong to the conserved HEXXGH motif, 
characteristic of the M49 family, which is part of an  α -helix. 
The third ligand, Glu508, is a constituent of the second 
conserved hexapeptide, E-E-(CAT)-(RK)-A-(ED), situated 
on the neighboring  α -helix. In all eukaryotic sequences 
of M49 peptidases, this linear motif is the hexapeptide 
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EECRAE (Abrami ć et al., 2004a ). Two other glutamic acid 
residues in EECRAE motif (Glu507 and Glu512 in human 
DPP III) are hydrogen bonded to the zinc-coordinating his-
tidine residues (His455 and His450). 
 Inhibition by thiol selective reagents is a general 
feature of all hitherto experimentally characterized M49 
peptidases, indicating the presence of a reactive cysteine 
residue in (or close to) the active site (Abrami ć et al., 
2004b ; Jaj č anin-Jozi ć et al., 2010 ). As all known DPPs 
III are multicysteine proteins, and there is no 100 % con-
served Cys within the M49 family, the identity of reactive 
-SH groups important for activity seems to be species spe-
cific. Recently, we reported that modification of Cys639 
and Cys518 leads to catalytic inactivation of the yeast DPP 
III (Jaj č anin-Jozi ć et al., 2010 ). Human DPP III has a total 
of six cysteines, three in the lower (Cys19, Cys147, and 
Cys176) and three in the upper domain (Cys509, Cys519, 
and Cys654) (Figure  1 ). Our previous study on an enzyme 
purified from human erythrocytes has revealed its inhibi-
tion by several sulfhydryl-modifying reagents, including 
the oxidized glutathione, and especially high sensitiv-
ity toward organomercurial compounds (Abrami ć et al., 
2000, 2004b ). To elucidate the molecular determinants of 
human DPP III inactivation by thiol reagents, we prepared 
six mutated enzyme forms with single cysteine to alanine 
substitutions and examined their properties. In addition, 
we employed the mass spectrometry (MS) approach to 
identify the target sites for oxidized glutathione on human 
DPP III. 
 Results 
 Expression, purifi cation, and biochemical 
characterization of wild-type and mutant 
DPP III proteins 
 Each of the cysteine residues (positions 19, 147, 176, 509, 
519, and 654 in the amino acid sequence) in human DPP III 
molecule was substituted by alanine independently. The 
wild-type and DPP III mutants were purified as His-tagged 
proteins of molecular mass  ~ 82 kDa. Figure  2 shows the 
purification profile for the wild-type DPP III. 
 The catalytic properties of the wild-type and all 
mutated forms were determined for the hydrolysis of 
characteristic synthetic substrate Arg-Arg-2-naphthyl-
amide (Arg 2 -2NA) (Table  1 ). The single mutants C19A, 
C147A, C509A, C519A, and C654A exhibited comparable 
kinetic parameters to the wild-type enzyme. However, 
replacement of Cys176 with Ala increased the K M value 
 Figure 1   Overview of the human DPP III crystal structure (Protein 
Data Bank code: 3fvy). 
 Cysteine residues are presented as red sticks, and the catalytic 
zinc ion is shown as a gray sphere. The drawing was performed by 
PyMOL ( www.pymol.org ). 
 Figure 2   SDS-PAGE profile of total cell lysate and the purification 
progress of human DPP III-His 6 protein on Ni-NTA agarose column. 
 Lanes: 1, molecular mass marker; 2, total  Escherichia coli cell lysate 
of uninduced sample; 3, total cell lysate of induced sample; 
4, solubilized precipitate after cell lysate centrifugation; 5, cleared 
cell lysate (supernatant after centrifugation); 6, flow-through Ni-NTA 
column; 7, wash with 20 m m imidazole; 8 – 9, human DPP III-His 6 
protein eluted with 150 m m imidazole. Proteins were stained with 
Coomassie Blue. 
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for Arg 2 -2NA threefold, and decreased the k cat about four-
fold, thus lowering the catalytic efficiency by an order of 
magnitude. 
 We further investigated if decreased hydrolytic activ-
ity of C176A reflects the change in protein structure. Cir-
cular dichroism (CD) spectroscopy in the far ultraviolet 
spectral region (Supplementary Figure  1 ) revealed almost 
identical CD spectra for the wild-type and C176A mutant, 
suggesting that Cys176-to-Ala substitution did not change 
human DPP III secondary structure. In addition, CD spec-
troscopy was used to monitor thermal denaturation of 
the C176A protein variant and the wild-type. A two-step 
unfolding was indicated for both, and the T m values did 
not differ significantly (51.0  ±  0.4 ° C and 70.5  ±  0.2 ° C for the 
C176A; 49.9  ±  0.3 ° C and 69.1  ±  0.2 ° C for the wild-type). Iden-
tical thermal stability suggested that the Cys176-to-Ala 
substitution did not affect overall stability of human DPP 
III. 
 Effects of cysteine substitution on the 
response to thiol-sensitive reagents 
 We investigated the effect of four SH group-modifying 
reagents on the activity of wild-type human DPP III and 
its cysteinyl mutants: para-hydroxymercuribenzoate 
(pHMB), N-ethylmaleimide (NEM), 4,4 ′ -dithiodipyridine 
(DTDP), and 5,5 ′ -dithiobis(2-nitrobenzoic acid) (DTNB). 
 As shown in Figure  3 A, as low as 0.01  μ m pHMB 
caused 50 % loss of catalytic activity of the wild-type and 
all mutants, except the C176A. When the reagent concen-
tration reached 0.1  μ m , inactivation was almost 100 % in 
the C19A, C147A, C654A, and the wild-type, 90 % in the 
C509A and C519A, while the C176A was resistant, exerting 
only 15 % lower activity. This enzyme variant was found 
resistant to up to 1  μ m pHMB (data not shown), which is 
A
B
 Figure 3   Inactivation of the wild-type human DPP III and of Cys-to-
Ala mutants by pHMB (A) and by DTDP (B). 
 The purified enzyme (2  ×  10 -10  m wild-type or any of Cys-to-Ala 
mutants, except the C176A, which was 3  ×  10 -9  m ) was preincubated 
with pHMB or DTDP in 50 m m Tris-HCl buffer, pH 8.6 at 25 ° C for 
10 min. Then, the residual activity was determined by a standard 
assay at 37 ° C with Arg 2 -2NA as a substrate. Presented are averages 
of at least two determinations. 
DPP III form  K m ( μ m )  k cat (/s)  k cat / K m 
(/ μ m s)
Wild-type 10.2  ±  0.6 50.8  ±  9.2 5.0  ±  1.2
C19A    5.8  ±  0.2 52.0  ±  0.5 8.9  ±  0.2
C147A    6.6  ±  0.4 58.6  ±  1.2 8.9  ±  0.7
C176A 35.3  ±  9.4 13.5  ±  1.6 0.39  ±  0.06
C509A    7.6  ±  1.8 34.4  ±  2.7 4.6  ±  0.7
C519A 12.2  ±  1.0 29.7  ±  9.9 2.4  ±  0.6
C654A    7.5  ±  1.8 55.7  ±  7.6 7.6  ±  0.8
 Table 1   Kinetic characterization of DPP III mutant proteins. 
 The kinetic parameters were determined from the initial reaction 
rates at 25 ° C and at pH 8.6 in the presence of 50  μ m CoCl 2 , with the 
substrate (Arg 2 -2NA) ranging from 2.5 to 60  μ m , using a Hanes plot. 
Mean values  ±  SD are given. 
almost 2 orders of magnitude higher than the concentra-
tion that caused inactivation of other mutated forms. 
 All human DPP III variants were resistant to sulfhy-
dryl-alkylating agent NEM, which only in 20 m m concen-
tration decreased the wild-type activity by 30 % (data not 
shown). 
 The aromatic disulfide DTDP is an amphiphilic 
uncharged reagent known to access the thiols located in 
a hydrophobic environment (Hansen and Winther , 2009 ). 
 DTDP, in a concentration range of 3 – 100  μ m , inacti-
vated the wild-type and C19A, C147A, C519A, and C654A to 
the similar extent (Figure 3B). However, the enzyme vari-
ants lacking Cys176 or Cys509 showed high, respectively, 
moderate resistance. 
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 DTNB (5 m m ) caused rapid inactivation of human DPP 
III at pH 7.4 and 23 ° C: after only 30 s preincubation, the 
loss of enzyme activity was 55 % (the C176A variant) to 
75 % (the wild-type) (Table  2 ). Further incubation up to 30 
min did not increase the inactivation extent significantly 
(Table 2). The C509A variant behaved as the wild-type. 
C19A and C654A seemed to be less inactivated than the 
wild-type, and the absence of Cys519 increased the inacti-
vation rate (Table 2). 
 Results indicate, beside Cys176, two other residues 
reactive with DTNB  – Cys19 and Cys654. The modifi-
cation of Cys176 seems to contribute to the observed 
enzyme inactivation slightly more than those of Cys19 
and Cys654. 
 Influence of oxidized glutathione 
(glutathione disulfide, GSSG) on DPP 
III activity 
 At first, concentration dependence of GSSG on the wild-
type DPP III activity was investigated. After a 30-min 
incubation at 25 ° C at physiological pH, GSSG, in concen-
trations above 2 m m , decreased the enzyme ’ s activity to 
about 20 % of the original value (data not shown). 
 To find out if any single cysteine residue is respon-
sible for the observed inactivation of human DPP III by 
GSSG, all prepared enzyme forms were incubated with 
3 m m GSSG at pH 7.4. Under these conditions, the wild-
type and two mutants, C19A and C147A, lost about 90 % 
of activity, while C176A and C519A retained significantly 
more activity than the wild-type (Table  3 ). 
 Obtained results showed that the inactivation effect of 
GSSG cannot be ascribed to the modification of only one 
cysteine residue (Table 3). 
 Identification of glutathionylation sites 
of human DPP III 
 To identify human DPP III Cys residues which are the glu-
tathionylation sites, mass spectrometric analysis of GSSG-
modified enzyme was performed as described in the Mate-
rials and methods. 
 The wild-type enzyme was reacted with 3 m m GSSG 
for 30 min at room temperature. Subsequently, GSSG-
treated DPP III was alkylated with 2-iodoacetamide (IAM), 
and the protease digestion was performed. Resulting 
peptide mixture was analyzed by on-line reverse-phase 
LC tandem MS (as described in the Materials and methods 
section). Obtained tandem MS spectra were matched 
against protein sequence of human DPP III (UniProtKB 
entry: Q9NY33). Additional crosscheck against common 
contaminants database returned no significant matches. 
 Tryptic digestion yielded a sequence coverage of 74 % , 
and five peptides containing cysteine residues (Cys 19, Cys 
147, Cys 176, Cys 509, Cys 654) were identified (Table  4 ). 
Despite our efforts (different digestion conditions and 
optimizing digestion protocol), the peptide containing 
Cys 519 residue was not observed, most likely due to the 
fact that it is relatively large (38 amino acids) and hydro-
phobic. In order to produce smaller proteolytic fragments, 
a chymotryptic digestion was performed. The chymo-
tryptic map resulted in a coverage of 76 % and revealed a 
peptide containing Cys 519. 
 Tandem MS data of both (tryptic and chymotryp-
tic) peptide maps yielded comparative results. Taken all 
together, tandem MS characterization showed glutath-
ionylation as well as carboxyamidomethylation on Cys 
residues 147, 176, and 654 (Table 4). By contrast, peptides 
Enzyme form Residual activity ( % )
   0.5 min 30 min
Wild-type 27.8  ±  2.9 24.8  ±  2.0
C19A 37.9  ±  2.3 32.5  ±  0.9
C147A 36.1  ±  4.5 32.3  ±  4.7
C176A 44.8  ±  5.6 45.1  ±  2.8
C509A 29.7  ±  0.0 24.3  ±  0.3
C519A 19.4  ±  0.1 15.1  ±  1.9
C654A 34.9  ±  0.8 29.9  ±  1.4
 Table 2   Influence of DTNB on the activity of human DPP III. 
 The enzyme (1.4  ×  10 -7  m ) was incubated with 5 m m DTNB in 0.25  m 
Tris-HCl buff er, pH 7.4 at 25 ° C for 0.5 or 30 min. Aliquots (3 to 7  μ l) 
were taken at the indicated times and residual activity determined 
by standard assay. Mean values  ±  SD are given. 
Enzyme form Residual activity ( % )
15 min 30 min
Wild-type 11.6  ±  4.4    8.5  ±  2.6
C19A 11.4  ±  1.0    8.1  ±  2.9
C147A 10.7  ±  0.0    8.1  ±  3.4
C176A 38.6  ±  4.3 25.6  ±  3.6
C509A 17.1  ±  2.8 12.5  ±  2.1
C519A 30.9  ±  2.8 23.6  ±  2.7
C654A 15.7  ±  0.8 13.2  ±  0.4
 Table 3   Influence of oxidized glutathione on the activity of 
wild-type and cysteinyl mutants of human DPP III. 
 The enzyme (1.3  ×  10 -7  m ) was incubated for 15 or 30 min with 3 m m 
GSSG at 25 ° C and pH 7.4 (25 m m Tris-HCl buff er). Aliquots (2 to 25 
 μ l) were taken at the indicated times and the residual activity 
determined by standard activity assay. Mean values  ±  SD are given. 
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containing Cys 19, Cys 509, and Cys 519 were found only to 
be carboxyamidomethylated. 
 Combined results of mutational analysis and MS 
suggest that glutathionylation (formation of mixed 
disulfide) of Cys176 and Cys654 contributes to human DPP 
III inactivation by oxidized glutathione. 
 Discussion 
 Finding that only the C176A protein retained substantial 
enzymatic activity upon treatment with submicromo-
lar pHMB is consistent with this residue being essential 
for the inactivation of human DPP III mediated by this 
organomercurial compound. Li et al.  (2000) investigated 
the properties of the recombinant rat DPP III using site-
directed mutagenesis approach and found that only 
Cys176-to-Ala mutant is resistant to both  p -chloromer-
curibenzoic acid (PCMB, in submicromolar concentration 
range) and NEM (up to 2 m m ). Human DPP III is highly 
homologous (93.5 % identity of the amino acid sequence) 
to its rat counterpart. The results of our present study 
demonstrate significant differences in sensitivity of the 
wild-type human enzyme toward the organomercurial 
compound (it is much higher), and toward NEM (it is much 
lower), compared to the rat DPP III. Li et al. concluded 
that out of a total of seven cysteine residues in the rat DPP 
III (positions 19, 147, 176, 509, 519, 654, and 701), Cys176 is 
essential for the regulation of rat DPP III activity. However, 
our present findings of the influence of five different SH 
group modifiers on the human DPP III demonstrate that a 
variety of sulfhydryl reagents are able to inactivate human 
DPP III, but except for the organomercurial compound 
pHMB, inactivation cannot be explained by the modifica-
tion of only one cysteine residue. 
 The K M value of the rat C176A mutant was unchanged, 
and the k cat (and k cat /K M ) was lowered about twofold com-
pared to the wild-type (Li et al. , 2000 ). In contrast, the 
human variant lacking Cys176 was found to be significantly 
less active (12-fold decrease in k cat /K M value). Observed 
change in K M value indicates that Cys176 may contribute to 
the substrate binding of human DPP III. This is supported 
by our previous finding that the peptide substrate protects 
the human DPP III from inactivation by pHMB (Abrami ć 
et al., 2004b ). The difference in thiol sensitivity and cata-
lytic properties of C176A mutants of the recombinant rat 
and human enzyme is not surprising, as earlier compara-
tive investigation of native enzymes (purified from human 
and rat erythrocytes) indicated non-identity in their active 
site topology (Abrami ć et al., 2000 ). So far, no 3-D struc-
ture of the rat enzyme is available, and detailed structural 
comparison is not possible. 
 Our results point to the Cys176 as the residue reactive 
with various SH reagents (pHMB, DTDP, DTNB) and GSSG. 
However, modification of Cys176 is critical for the inactiva-
tion of human DPP III only with the organomercurial com-
pound. In addition to Cys176, at least three other cysteine 
residues (Cys147, Cys509, and Cys654) are able to react 
with different thiol-selective compounds, including the 
biologically active GSSG, and may contribute to (revers-
ible) inactivation of the enzyme. 
 The reactivity of protein cysteinyl thiols is regulated 
by a number of factors: exposure to a solvent, dissociation 
to the thiolate anion, reactivity of the SH reagent, nature 
of the leaving group of the reagent, charge compatibility 
Fragment Cys 
residue
Amino acid sequence [M + H]  +  m [M + H]  +  c  Δ 
   1 – 20    19 MADTQYILPNDIGVSSLD C R 2426.28 2426.133 0.147
142 – 157 147 GLWQT C GELMFSLEPR  1924 .068 1923.909 0.159
145 – 152 147 QT C  *  GELMF 1233.472 1233.458 0.014
166 – 182 176 EGTTTYFSGN C TMEDAK 1911.858 1911.774 0.084
166 – 182 176 EGTTTYFSGN C  *  TMEDAK 2159.838 2159.82 0.018
499 – 510 509 FSTIASSYEE C R 1449.652 1449.631 0.021
518 – 528 519 L C LHPQVLEIF 1368.724 1368.734 0.01
639 – 659 654 ALYEGYATVTDAPPE C FLTLR 2387.1 2387.159 0.059
639 – 659 654 ALYEGYATVTDAPPE C  *  FLTLR 2635.29 2635.205 0.085
 Table 4   Characterized Cys-containing peptides resulting from the human DPP III protease digests. 
 c , calculated;  m , measured and deconvoluted.  Glutathionylated Cys are shown in bold, with asterisk, while carboxyamidomethylated 
Cys are underlined. Accompanying tandem MS spectra are given as supporting data (Supplementary Figures 2 – 10 and corresponding Sup-
plementry Tables 2–10). The wild-type human DPP III was glutathionylated, digested by trypsin or chymotrypsin, and analyzed by LC-MS/MS 
as described in the Materials and methods section. 
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Residue Atom Distance
( Å )
Lys202 Nitrogen of  ɛ -amino 5.26
Arg325 Nitrogen of guanidino 8.14
Asp180 Oxygen of carboxylate 4.36
Ser173 Hydroxyl oxygen 3.54
 Table 5   Distances from Cys176 to neighboring residues. 
 Distances were measured with PyMOL ( www.pymol.org ) from the 
sulfur of Cys176 to the listed atom, using the crystal structure of the 
human DPP III (code 3fvy in Protein Data Bank). 
between the reagent and cysteine environment, and sta-
bility of the bonds formed (Britto et al. , 2002 ). Consider-
ing the local surrounding, ionization of the SH groups is 
enhanced by the neighboring basic amino acids and sup-
pressed by acidic groups. To explain the observed differ-
ences in the reactivity of human DPP III cysteinyl residues, 
we analyzed their location and microenvironment in the 
protein crystal structure (Supplementary Table  1 ). Only 
Cys654 was found to be highly surface exposed, while 
Cys19, Cys147, and Cys176 are located near the external 
surface, but are not directly exposed to the solvent. The 
surface- or near-surface location correlates well with the 
reactivity toward GSSG for all residues (Cys654, Cys147, 
and Cys176) except the Cys19 whose modification was not 
detected by MS. The lack of reactivity of Cys19 could be 
explained by the absence of any neighboring positively 
charged group, and the presence of Asp377 in the prox-
imity (5.2  Å apart) of the sulfur, which may suppress the 
formation of thiolate anion, but also produce the charge 
repulsion due to the incompatibility with the negatively 
charged reagent (GSSG). 
 Our results indicate Cys176 as probably the most reac-
tive cysteine residue in human DPP III. Inspection of the 
location and environment of this residue in the X-ray 
crystal structure supports this conclusion (Table  5 ). The 
 ɛ -amino group of Lys202, 5.3  Å apart, faces the sulfur of 
Cys176 and could promote ionization of the thiol group. 
Arg325 is the other basic residue near Cys176 (Table 5), 
but the distance to its guanidino group is 8.1  Å . There is 
also one acidic residue on the 4.4- Å distance (Asp180). 
However, additional influence on the lowering of the pKa 
of Cys176 could be exerted through a potential hydrogen 
bond between its SH group and the Ser173 which are only 
3.5  Å apart (Table 5). 
 In addition to Cys176, whose reactivity is governed by 
its microenvironment and near-surface location, the hydro-
phobic pocket-buried Cys509 from the conserved EECRAE 
motif seemed to contribute to human DPP III inactivation 
by the aromatic disulfide DTDP (Figure 3B). Interestingly, 
the structurally equivalent Cys518 contributed signifi-
cantly to the inactivation of the yeast DPP III with the same 
compound (Jaj č anin-Jozi ć et al., 2010). These findings are 
in agreement with DTDP being an amphiphilic reagent 
able to access even buried sulfhydryl groups in proteins. 
 Prokaryotic M49 peptidases were discovered only 
recently, when their deduced amino acid sequences 
became available in public data bases (Abrami ć et al., 
2004b ). Majority of bacterial M49 peptidases comprise 
the conserved HECLGH motif. Unlike the eukaryotic 
members of the family, they contain a cysteine residue in 
close pro ximity to the catalytically essential Glu and to the 
two zinc-coordinating histidines. Most recently, we have 
reported that the Cys residue, from the active-site motif 
of the  Bacteroides thetaiotaomicron DPP III, is wholly 
responsible for the inactivation by sulfhydryl reagents 
(Vukeli ć et al., 2012 ). The activity of yeast  Saccharomyces 
cerevisiae DPP III was sensitive to the modification of two 
cysteine residues (Cys518 and Cys639). Based on those 
previous findings and our present study indicating at least 
three Cys in human DPP III whose chemical modification 
can influence the enzyme activity, it is clear that differ-
ent mechanisms of the M49 peptidase thiol sensitivity are 
involved in different organisms. It seems that the number 
of  “ responsible ” cysteines in DPP III family members 
increases with the complexity of the species (organism) 
from which they originate. 
 The results presented here provide experimental 
verification for prediction that highly reactive cysteine 
residue(s) is a part of the substrate-binding site of the 
mammalian DPPs III (Abrami ć et al., 2004b ). Now, we 
have identified the highly reactive Cys176, which seems 
to contribute to the substrate binding to human DPP III. 
Surprisingly, this residue is located in the amino-terminal 
protein domain, which is considered to be noncatalytic. 
It is not clear how the Cys176, which is near the protein 
surface and at a 43.7- Å distance from the zinc ion in the 
crystal structure of ligand-free human DPP III, could 
influence the substrate binding and how the modifica-
tion of this residue by pHMB could cause complete inac-
tivation of the enzyme. A possible explanation would be 
that human DPP III adapts also a more flexible confor-
mation in solution, allowing the two domains ( “ upper ” 
and  “ lower, ”  “ catalytic ” and  “ noncatalytic ” ) to operate in 
close proxi mity and thereby enabling Cys176 to participate 
in substrate binding. Whether the two conformations are 
present in equilibrium in solution, or the ligand binding 
triggers the conformational change (interdomain mobil-
ity), which is accompanying the catalytic cycle, is yet 
unknown and worthy of further investigations. 
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 It has been reported that human insulin-degrading 
enzyme (IDE), which belongs to the evolutionary dis-
tinct family of zinc metallopeptidases (M16), undergoes 
a switch between the closed and opened conformations 
for catalysis (Im et al. , 2007 ). The conformational changes 
accompanying the catalytic cycle of the carbamoyl phos-
phate synthetase have also been documented (Hart and 
Powers -Lee, 2009 ). 
 Our present study shows that human DPP III can be 
glutathionylated under the oxidative stress conditions 
when m m concentrations of GSSG can be observed. 
 The data of the MS analysis suggest that the glutath-
ionylation of the three cysteine residues (Cys176, Cys654, 
and Cys147) might be involved in the inactivation of 
human DPP III wild-type by oxidized glutathione. Inter-
estingly, the residual activity assay pointed to Cys176 and 
Cys519. As the glutathionylation of Cys519 was not con-
firmed by MS, and the variant lacking Cys176 was highly 
sensitive to GSSG, modification of another cysteine(s) is 
involved in observed DPP III inactivation. 
 Glutathionylation of proteins is reversible, as those 
proteins can be reduced by glutaredoxins, and the process 
serves to regulate protein functions by the redox state of 
the cell (i.e., by the GSSG/GSH ratio) (Casagrande et al. , 
2002 ). Glutathionylation of human DPP III, as reversible 
modification, may provide protection against oxidative 
inactivation. In addition, as various biological events, 
including redox signaling, utilize proteins containing 
reactive sulfhydryls, DPP III cysteine residues may be 
important for (intracellular) protein interactions and 
yet with an unknown biological function different from 
proteolysis. 
 Although the potential role in protection against oxi-
dative stress has been ascribed to human DPP III (Liu et 
al. , 2007 ), a corresponding molecular mechanism remains 
unknown. 
 Taken together, the results of this investigation 
provide new information about the reactivity of individual 
cysteine residues within the human DPP III, which could 
be useful for further functional studies of the enzyme. 
The finding that Cys176, a residue from the lower domain, 
quite distant from the catalytic zinc ion, is responsible for 
the fast inactivation of the enzyme by the organomercu-
rial compound and contributing to enzyme inactivation 
by DTDP, DTNB, and GSSG, provides the evidence that the 
active site (the substrate-binding site) of human DPP III 
comprises both protein domains, which in the active form 
of the enzyme need to be in close contact. 
 We conclude that Cys176 is not directly involved in 
catalysis, but that is, in the active (closed) form of the 
enzyme located in (or close to) the substrate-binding site 
and contributes to the ligand binding, so that the modi-
fication of this cysteine residue hinders the function of 
human DPP III. 
 Materials and methods 
 Chemicals 
 NEM, IAM, DTDP, pHMB, DTNB, formic acid, HPLC-grade water, 
and acetonitrile, as well as proteomics-grade trypsin were obtained 
from Sigma-Aldrich (St. Louis, MO, USA). Sequencing-grade chymo-
trypsin was purchased from Roche Applied Science (Mannheim, 
Germany) and nickel-nitrilotriacetic acid (Ni-NTA) agarose from Qia-
gen (Hilden, Germany). GSSG was a product of Serva (Heidelberg, 
Germany), and L-Arg-L-Arg-2-naphthylamide (Arg 2 -2NA) trihydrochlo-
ride, from Bachem (Bubendorf, Switzerland). 
 Cloning and site-directed mutagenesis 
 To obtain the DPP III protein with affi  nity C-terminal six-histidine 
tag, full cDNA for DPP III (2.214 kb, contained originally in the clone 
IRALp962E0242Q2) (Salopek -Sondi et al., 2008 ) was cloned into pET-
21b vector between the  NheI and  XhoI restriction sites as described 
earlier ( Š poljari ć et al., 2011 ). Thus, the obtained wild-type expression 
vector was used for further mutagenesis and protein expressions. 
Construct Oligonucleotide (5′ → 3 ′ )
Forward Reverse
pET21b-DPPIII6His C19A GTG TCT AGC CTG GAC  GCC CGT GAG GCC TTC C G GAA GGC CTC ACG GGC GTC CAG GCT AGA CAC
pET21b-DPPIII6His C147A GGC CTC TGG CAG ACC  GCC GGG GAG CTT ATG CAT AAG CTC CCC GGC GGT CTG CCA GAG GCC
pET21b-DPPIII6His C176A CC TAT TTC TCT GGG AAT  GCT ACC ATG GAA GAT GCC GGC ATC TTC CAT GGT AGC ATT CCC AGA GAA ATA GG
pET21b-DPPIII6His C509A CC AGC TAC GAA GAG  GCC CGG GCT GAG AGC GTG GG CC CAC GCT CTC AGC CCG GGC CTC TTC GTA GCT GG
pET21b-DPPIII6His C519A GTG GGT CTC TAC CTC  GCT CTC CAC CCG CAA GTG CAC TTG CGG GTG GAG AGC GAG GTA GAG ACC CAC
pET21b-DPPIII6His C654A GAT GCG CCC CCC GAG  GCC TTC CTC ACC CTC AGG CCT GAG GGT GAG GAA GGC CTC GGG GGG CGC ATC
 Table 6   Oligonucleotides used for PCR-based site-directed mutagenesis. 
 The codons changed are underlined and appear in bold. 
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 The production of cysteine-to-alanine point mutations was per-
formed by means of the QuikChange II XL Site-Directed Mutagenesis 
kit (Stratagene, La Jolla, CA, USA) and the primers listed in Table  6 . 
The sequencing of the complete DPP III gene, as well as confi rmati-
on of each mutant, was obtained with automated sequence analy-
zer "ABI PRISM  ®  3100-Avant Genetic Analyzer" (Applied Biosystems, 
Concord, MA, USA). 
 Expression and purification of the enzymes 
 Heterologous expression of recombinant DPP III with C-terminal six-
histidine tag, and purifi cation on Ni-NTA agarose was performed as 
described by  Š poljari ć et al. (2011) . 
 Protein purity was confi rmed by polyacrylamide gel electropho-
resis (PAGE) under native and denaturing conditions (SDS-PAGE) 
carried out according to the method of Laemmli  (1970) . All fractions 
of high purity (according to the SDS-PAGE analysis) were pooled 
and desalted on PD-10 columns (Amersham Biosciences, Vienna, 
Austria) equilibrated with 20 m m Tris-HCl buff er (pH 7.4) containing 
1 m m NaCl. To the purifi ed protein preparations, glycerol was added 
to 22 % , and they were stored at -10 ° C. 
 Protein concentrations were determined using the protein-dye 
binding assay, with bovine serum albumin as a standard (Bradford , 
1976 ). 
 Enzyme activity assay and determination 
of kinetic parameters 
 The enzymatic activities of the wild-type DPP III and enzyme variants 
were determined by a standard assay at 37 ° C with Arg 2 -2NA as a sub-
strate (Abrami ć et al., 2004b ). Kinetic parameters were determined 
at 25 ° C and at pH 8.6, in the presence of 50  μ m CoCl 2 by initial rate 
measurements ( Š poljari ć et al., 2009 ). 
 Circular dichroism (CD) measurements 
 CD spectra were recorded on Jasco J-815 spectropolarimetar with 
automatic temperature control using a quartz cuvette of 0.1 mm 
path length. Enzyme samples were prepared for CD measurements 
by exchange into 10 m m Tris-HCl buff er, pH 7.4. The protein concen-
trations used were from 0.31 to 0.39 mg/ml. Recording of the far-
UV spectra, acquisition of thermal denaturation data, and analysis 
of protein secondary structure from CD spectra were performed as 
described (Jaj č anin-Jozi ć et al., 2010 ). 
 Inactivation by sulfhydryl reagents and 
glutathione disulfide 
 The purifi ed enzyme (2  ×  10 -10  m wild-type or any of the Cys-to-Ala 
mutants, except the C176A, which was 3  ×  10 -9  m ) was preincubated 
with pHMB (0.003 to 0.1  μ m ) or DTDP (3 to 100  μ m ) in 50 m m Tris-HCl 
buff er, pH 8.6 at 25 ° C for 10 min. Then, the substrate Arg 2 -2NA was 
added and residual activity determined under the standard assay 
conditions. 
 NEM, in a concentration range of 1 – 20 m m , was preincubated 
with an enzyme (2.0  ×  10 -7  m ) in 100 m m sodium phosphate buff er, pH 
7.0 at 25 ° C. Ten  μ l aliquots were taken aft er 10 min for the determina-
tion of residual activity at pH 8.6. 
 DTNB, 5 m m , and 1.4  ×  10 -7  m enzyme were preincubated in 
0.25  m Tris-HCl buff er, pH 7.4 at 25 ° C for 0.5 min or 30 min. Three- 
to seven-microliter aliquots were taken for the remaining activity 
determination. 
 When modifi cation with oxidized glutathione (GSSG) was inves-
tigated, typically, the enzyme (1.3  ×  10 -7  m ) was incubated for 15 or 30 
min at 25 ° C in a total volume of 150  μ l of reaction mixture pH 7.4 (25 
m m Tris-HCl buff er) with 3 m m GSSG, added from a stock solution of 
50 m m GSSG dissolved in 25 m m Tris-HCl buff er, pH 7.4. Residual 
DPP III activity was determined at the end of incubation, with 2 to 
25  μ l aliquots taken for a standard activity assay. 
 For MS analysis, the reaction with GSSG (glutathionylation) 
was terminated by the addition of IAM to 0.05  m , followed by 20 min 
incubation at 25 ° C, and 5 min incubation at 95 ° C. Aft er 40 min at 
25 ° C, the sample was digested by trypsin, during a 1-h incubation 
at 37 ° C in 80 % acetonitrile, 20 % 50 m m Tris-HCl, 10 m m CaCl 2 pH 
7.6 (v/v) (Strader et al. , 2006 ), with 1:20 w/w ratio of trypsin and 
DPP III, or chymotrypsin (incubation for 2 h at 25 ° C in 15 m m Tris-HCl 
pH 8.6 with 10 m m CaCl 2 , 1:20 w/w ratio of chymotrypsin and DPP III, 
as suggested in the Roche Protocols). 
 Liquid chromatography (LC) separation and 
tandem mass spectrometry (MS/MS) 
 Online LC-MS/MS analysis was performed on a Bruker amaZon ETD 
ion trap system (Bruker Daltonik GmbH, Bremen, Germany) cou-
pled with an Ultimate 3000 RSLCnano system (Dionex, Amsterdam, 
Netherlands). The sample injection, enrichment, separation, and 
MS acquisition was carried out automatically. The peptide mixture 
was loaded (1  μ l injection volume) onto the trapping column (Nano 
Trap Column, 75  μ m I.D.  ×  2 cm, Acclaim PepMap100 C18, 3  μ m, 
100  Å , Dionex, Amsterdam, Netherlands) with a solvent mixture of 
0.1 % formic acid in CH 3 CN/H 2 O (2:98, w/w) at a fl ow rate of 20  μ l/min. 
For peptide separation Nano Trap Column, 75  μ m I.D.  ×  2 cm, packed 
with Acclaim PepMap100 C18, 3  μ m, 100  Å (Dionex) was used. Pep-
tides were separated with a 80 min linear gradient from 2 % to 40 % 
acetonitrile in 0.1 % formic acid at the fl ow rate of 300 nl/min. 
 The nano-spray capillary voltage was set as -1500 V, while high-
voltage end plate off set was -500 V. The temperature and fl ow rate of the 
drying gas were set at 140 ° C and 5 l/min, respectively. Helium was used 
as the collision gas. The fragmentation amplitude was set at 1 V and 
ramped between 30 % and 200 % of this value. Product ion spectra were 
sequentially recorded for each selected precursor. The acquisition soft -
ware was set up in autoMSMS mode using three to four precursor ions 
with active exclusion on (precursor exclusion aft er two MSMS spectrum 
for 0.3 min). MS spectra were acquired within a scan range from 300 
to 3000 m/z and a scan speed of 8100 (m/z)/s using averages from fi ve 
spectra. MSMS spectra were acquired within a scan range from 100 to 
2400 m/z and a scan rate of 8100 (m/z)/s using averages from 2 spectra. 
 DataAnalysis soft ware 4.0 (Bruker Daltonik GmbH, Bremen, 
Germany) was used to extract MS and MS/MS data. Protein sequence 
assignment was attempted using BioTools 3.2 (Bruker Daltonik 
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GmbH, Bremen, Germany). The maximum number of miscleavages 
for trypsin was set as one per peptide, while for chymotrypsin, it was 
set as up to six per peptide. 
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